Overview and Scope
Malaria vaccines are specific vaccines designed to prevent malaria, a potentially deadly mosquito-borne infectious disease caused by parasites from the Plasmodium genus. These vaccines aim to provide immunity against the plasmodium parasites that cause malaria.
Sizing and Forecast
The malaria vaccines market size has grown exponentially in recent years. It will grow from $3.48 billion in 2023 to $4.7 billion in 2024 at a compound annual growth rate (CAGR) of 35.2%. The growth in the historic period can be attributed to high malaria burden, global health initiatives, funding and grants, malaria control programs, government support and regulatory frameworks.
The malaria vaccines market size is expected to see exponential growth in the next few years. It will grow to $15.32 billion in 2028 at a compound annual growth rate (CAGR) of 34.3%. The growth in the forecast period can be attributed to global elimination goals, expanded access programs, increasing vaccine coverage, global vaccine alliances, climate change impact. Major trends in the forecast period include technological innovations, public-private partnerships, international collaboration, advancements in vaccine technology, advancements in vaccine technology.
Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/malaria-vaccines-global-market-report
Segmentation & Regional Insights
The malaria vaccines market covered in this report is segmented –
1) By Agent: Plasmodium Falciparum, Plasmodium Vivax, Anopheles Species
2) By Vaccine Type: Pre-Erythrocytic, Erythrocytic, Multi-antigen, Other Vaccines
3) By Route of Administration: Intramuscular, Subcutaneous, Intradermal, Other Routes
4) By Distribution Channel: Public, Private
North America was the largest region in the malaria vaccines market in 2023. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the malaria vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13698&type=smp
Major Driver Impacting Market Growth
A rise in the incidence of mosquito-related diseases is expected to propel the growth of the malaria vaccine market going forward. Mosquito-related diseases are a broad category of illnesses spread by the bite of an infected mosquito. The malaria vaccine, particularly the RTS, S/AS01 (RTS, S) vaccine, is used to prevent and reduce the impact of mosquito-borne infectious diseases by training the immune system to recognize and attack the parasite. For instance, in November 2023, according to a report published by the World Health Organization, a Switzerland-based intergovernmental organization, estimated 249 million cases of malaria occurred globally in 2022, with an increase of 5 million cases from 2021. Further, Pakistan reported an estimated 2.6 million cases in 2022, a notable increase from the 500,000 cases reported in 2021. Therefore, the rise in the incidence of mosquito-related diseases is driving the growth of the malaria vaccine market.
Key Industry Players
Major companies operating in the malaria vaccines market report are Pfizer Inc., Ipca Laboratories Ltd., Novartis AG, Sanofi SA, GlaxoSmithKline Plc., Takeda Pharmaceutical Co Ltd. , Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC., Lupin, Taj Pharmaceuticals Limited., Nobelpharma Co. Ltd., Bliss GVS Pharma Ltd., Sanaria Inc., Precigen Inc., AdvaCare Pharma, CellFree Sciences, Actiza Pharmaceutical Private Limited, Sumaya Biotech, VLP Therapeutics LLC, GeoVax Labs Inc., Zydus Cadila, Genvec Inc.
The malaria vaccines market report table of contents includes:
1. Executive Summary
2. Malaria Vaccines Market Characteristics
3. Malaria Vaccines Market Trends And Strategies
4. Malaria Vaccines Market - Macro Economic Scenario
5. Global Malaria Vaccines Market Size and Growth
.
.
.
32. Global Malaria Vaccines Market Competitive Benchmarking
33. Global Malaria Vaccines Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Malaria Vaccines Market
35. Malaria Vaccines Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Hemasri Paruchuri 
